|
NIG-RNAi Strains Detail |
Request : Click the "Order" button to request for this stock |
discarded
|
Stock Detail (Last Update: November 2007_FlyBase version FB2007_11) |
Stock ID |
5802R-1 |
Symbol |
CG5802 |
Full Name |
CG5802 |
CG No |
CG5802 |
Old CG No |
CG5802 |
Synonyms |
unnamed, anon-EST:fe1H6, CG5802, anon-fast-evolving-1H6 |
Accession No (Link to NCBI) |
|
Inserted Chr. |
lll |
Insertional Mutation |
|
Phenotype induced by Act5C-GAL4 at 28 degrees |
lethal |
Map Viewer |
|
Reference
[Please submit your publication]
|
Yamamoto-Hino M, Yoshida H, Ichimiya T, Sakamura S, Maeda M, Kimura Y, Sasaki N, Aoki-Kinoshita KF, Kinoshita-Toyoda A, Toyoda H, Ueda R, Nishihara S, Goto S. Phenotype-based clustering of glycosylation-related genes by RNAi-mediated gene silencing. Genes Cells (2015) 20(6) 521-42
[
PubMed ID = 25940448
]
[
RRC reference
]
|
Comment |
|
Sequence (Last Update: July 10, 2007_NCBI RefSeq Release 24) |
Primer Seq. 5' |
aaggcctacatggccggaccgGGTACAGACAGATGGATCCGT |
Primer Seq. 3' |
aatctagaggtaccTCATCATCTGCTGACCGGAAG |
Predicted Fragment Size |
500 |
IR fragment full Seq |
|
in silico PCR Fragment |
|
Assemble Data |
5802R-1.IR full 1 GGTACAGACAGATGGATCCGTGGGAGAGCGCTTCACTTACGCCTTGGCCCTTGTTTGGGT 60
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5802R-1.in silico 1 GGTACAGACAGATGGATCCGTGGGAGAGCGCTTCACTTACGCCTTGGCCCTTGTTTGGGT 60
5802R-1.IR full 61 GCAGTGCCTCTGCAACTATGTGTTTGCCAAGGTGCTGCTGACCATTAGGCCGCAAAAGGA 120
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5802R-1.in silico 61 GCAGTGCCTCTGCAACTATGTGTTTGCCAAGGTGCTGCTGACCATTAGGCCGCAAAAGGA 120
5802R-1.IR full 121 GGACACCACCAACGCGGGCTCCTACGTGGCCTGTTCGCTGACCTATCTTCTGGCCATGGT 180
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5802R-1.in silico 121 GGACACCACCAACGCGGGCTCCTACGTGGCCTGTTCGCTGACCTATCTTCTGGCCATGGT 180
5802R-1.IR full 181 CTCCACCAATATGGCCATGCGCTGGGTTCCCTATCCCACTGCTGTGGTAGGTAAATCCGC 240
|||||||||||||||||||||||||||||||||||||||||||||||| |||||||||||
5802R-1.in silico 181 CTCCACCAATATGGCCATGCGCTGGGTTCCCTATCCCACTGCTGTGGTGGGTAAATCCGC 240
5802R-1.IR full 241 CAAGCCCATCCCCGTCATGATCCTGGGCGTGCTGATTGGTCGCAAATCCTACAGCTGGAC 300
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5802R-1.in silico 241 CAAGCCCATCCCCGTCATGATCCTGGGCGTGCTGATTGGTCGCAAATCCTACAGCTGGAC 300
5802R-1.IR full 301 GCGCTATGCTTGCGTATTGACCATTGTCCTGGGAGTTATTCTCTTTATGTACAAGGAGGG 360
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5802R-1.in silico 301 GCGCTATGCTTGCGTATTGACCATTGTCCTGGGAGTTATTCTCTTTATGTACAAGGAGGG 360
5802R-1.IR full 361 CAAGGTGTCCAATTTGCCGGCTGAGACCACGCTTCTCGGCGAGGTGCTGCTCTTCCTCAG 420
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5802R-1.in silico 361 CAAGGTGTCCAATTTGCCGGCTGAGACCACGCTTCTCGGCGAGGTGCTGCTCTTCCTCAG 420
5802R-1.IR full 421 TTTGTCAATGGACGGATTGACTGGAGCCGTTCAGGAGCGCATCCGAGCGGCCAGCGCGCC 480
|||||||||||||||||||||||||||||||||||| |||||||||||||||||||||||
5802R-1.in silico 421 TTTGTCAATGGACGGATTGACTGGAGCCGTTCAGGAACGCATCCGAGCGGCCAGCGCGCC 480
5802R-1.IR full 481 TTCCGGTCAGCAGATGATGAGG 502
||||||||||||||||||||
5802R-1.in silico 481 TTCCGGTCAGCAGATGATGA-- 502
|
Off-target information (Last Update: November 4, 2007_NCBI RefSeq Release 26) |
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
100 |
490 |
0 |
0 |
0 |
NM_142692.1 |
CG5802-RA (CG5802), mRNA |
0 |
0 |
4 |
3 |
5 |
NM_132322.2 |
ric8a CG15797-RA (ric8a), mRNA |
0 |
0 |
4 |
2 |
6 |
NM_165777.2 |
mitochondrial carnitine palmitoyltransferase I CG12891-RB, transcript variant B (CPTI), mRNA |
0 |
0 |
4 |
2 |
6 |
NM_078961.3 |
mitochondrial carnitine palmitoyltransferase I CG12891-RA, transcript variant A (CPTI), mRNA |
0 |
0 |
4 |
2 |
5 |
NM_165776.1 |
CG11777-RA (CG11777), mRNA |
0 |
0 |
2 |
4 |
2 |
NM_140446.2 |
CG3919-RA (CG3919), mRNA |
0 |
0 |
2 |
3 |
3 |
NM_135489.2 |
CG5846-RA (CG5846), mRNA |
0 |
0 |
2 |
3 |
2 |
NM_206564.1 |
CG5794-RE, transcript variant E (CG5794), mRNA |
0 |
0 |
2 |
3 |
2 |
NM_170158.1 |
CG5794-RB, transcript variant B (CG5794), mRNA |
0 |
0 |
2 |
3 |
2 |
NM_143018.2 |
CG5794-RD, transcript variant D (CG5794), mRNA |
0 |
0 |
2 |
2 |
2 |
NM_001032400.1 |
CG9850-RB, transcript variant B (CG9850), mRNA |
0 |
0 |
2 |
2 |
2 |
NM_137983.3 |
CG9850-RA, transcript variant A (CG9850), mRNA |
0 |
0 |
2 |
2 |
2 |
NM_169222.2 |
CG31462-RA (CG31462), mRNA |
0 |
0 |
1 |
4 |
4 |
NM_057920.3 |
Stromalin CG3423-RA (SA), mRNA |
0 |
0 |
0 |
4 |
6 |
NM_143453.1 |
CG7582-RA (CG7582), mRNA |
0 |
0 |
0 |
4 |
6 |
NM_001014606.1 |
CG1161-RB, transcript variant B (CG1161), mRNA |
0 |
0 |
0 |
4 |
6 |
NM_141271.2 |
CG1161-RA, transcript variant A (CG1161), mRNA |
0 |
0 |
0 |
4 |
6 |
NM_206496.1 |
CG14869-RB, transcript variant B (CG14869), mRNA |
0 |
0 |
0 |
4 |
6 |
NM_169659.2 |
CG14869-RA, transcript variant A (CG14869), mRNA |
0 |
0 |
0 |
4 |
3 |
NM_132230.2 |
slipper CG2272-RA (slpr), mRNA |
0 |
0 |
0 |
4 |
3 |
NM_079449.2 |
Adenylyl cyclase 76E CG7978-RA (Ac76E), mRNA |
0 |
0 |
0 |
4 |
3 |
NM_169704.1 |
CG32855-RA (CG32855), mRNA |
0 |
0 |
0 |
4 |
2 |
NM_168521.1 |
CG32108-RA (CG32108), mRNA |
0 |
0 |
0 |
3 |
10 |
NM_167595.3 |
Shaker CG12348-RE, transcript variant E (Sh), mRNA |
0 |
0 |
0 |
3 |
9 |
NM_167594.2 |
Shaker CG12348-RC, transcript variant C (Sh), mRNA |
0 |
0 |
0 |
3 |
9 |
NM_140127.1 |
CG8072-RA (CG8072), mRNA |
0 |
0 |
0 |
3 |
7 |
NM_169947.1 |
SNF4/AMP-activated protein kinase gamma subunit CG17299-RF, transcript variant F (SNF4Agamma), mRNA |
0 |
0 |
0 |
3 |
7 |
NM_165533.1 |
dappled CG1624-RA, transcript variant A (dpld), mRNA |
0 |
0 |
0 |
3 |
7 |
NM_165534.1 |
dappled CG1624-RB, transcript variant B (dpld), mRNA |
0 |
0 |
0 |
3 |
7 |
NM_080033.2 |
dappled CG1624-RC, transcript variant C (dpld), mRNA |
|
|
|